Prevalence of haemoglobinopathies in anemic females


  • Promil Jain Department of Pathology, Pt BD Sharma PGIMS, Rohtak, Haryana
  • Vinod Kumar Department of Pathology, Pt BD Sharma PGIMS, Rohtak, Haryana
  • Rajeev Sen Department of Pathology, Pt BD Sharma PGIMS, Rohtak, Haryana
  • Shilpi Bhargava Department of Pathology, Pt BD Sharma PGIMS, Rohtak, Haryana



Anemia, Hemoglobinopathies, Thalassemic syndromes, High performance liquid chromatography


Background: The β-thalassemias and various other hemoglobinopathies are a major health problem in India.  An accurate diagnosis of patients suffering from β-thalassemia syndrome and other hemoglobinopathies is important for prevention and management of major hemoglobin disorders. High-performance liquid chromatography (HPLC) is a highly sensitive and specific method for the accurate diagnosis of thalassemia and other hemoglobinopathies. 

Methods: Present study was conducted on 1400 females of reproductive age group for screening of hemoglobinopathies in a rural block of north India. Patients were evaluated for presence of anemia with detailed hematological workup. Anemia cases were further screened by HPLC system for presence of any hemoglobinopathy.

Results: 855 subjects out of a total of 1400 were found to be anemic. 359 patients had normocytic normochromic anemia, 399 had microcytic hypochromic picture, 37 had macrocytic picture, while 60 patients had dimorphic anemia. 47 cases were detected positive for various types of hemoglobinopathies. 36 patients were positive for β-thalassemia trait/ heterozygous forming the major portion (76.5%), while one (2%) patient was β-thalassemia intermedia / homozygous and was non-transfusion dependent. 3 patients were positive for HbE heterozygous and hereditary persistence of fetal hemoglobin each, two for HbD Punjab, one each for HbS heterozygous and Hb Lepore.

Conclusions: The detection of various hemoglobinopathies is the key to diagnosis and proper treatment of various types of anemia. Antenatal screening should be an integral part of workup in pregnant females to prevent morbidity related to hemoglobinopathies like thalassemias.


Rizwan F, Qamarunisa H, Memon A. Prevalence of anemia in pregnant women and its effects on maternal and fetal morbidity and mortality. Pak J Med Sci. 2010;26:92-5.

DeMayer EM, Tegman A. Prevalence of anaemia in the World. World Health Organ Qlty.1998;38:302-16.

Red blood cell and bleeding disorders. In: Kumar, Abbas, Aster, editors. Robbins and Cotran Pathologic Basis of disease. 9th ed. South Asia edition: Elsevier. 2014;638.

Weatherall DJ. Postgraduate Hematology. Hemoglobin and the inherited disorders of globin synthesis. 5th ed. Oxford Blackwell science. 2005;2:245-55.

Sood SK, Madan N, Colah R, Sharma S, Apte SV. Collaborative study on thalessemia-An ICMR Task Force Study, New Delhi. Indian Coun Med Res. 1993.

Weatherall DJ. Phenotype-genotype relationship in monogenic disease: lessons from thalassemias. Nat Rev Genet. 2001;2:245-55.

Gwendolyn M, Higgins C, Higgins T. Laboratory investigation of haemoglobinopathies and thalassemias. Review and update. Clin Chem. 2000;46:1284-90.

Galleleno R, Barella S, Gasperini D, Perseu L, Paglietti E, Sollaino C et al. Evaluation of an automatic HPLC analyser for thalassemia and hemoglobin variants screening. J Automat Chem. 1995;17:73-6.

Gupta PK, Kumar H, Kumar S, Jaiprakash BM. Cation exchange high performance liquid chromatography for diagnosis of hemoglobinopathies. MJAFI. 2009;65:33-7.

Colah R, Gorakshakar A, Nadkarni A. Global burden, distribution and prevention of beta thalassemias and hemoglobin disorders. Expert Rev Hematol. 2010;3:103-17.

George E, Jamal AR, Khalid F, Osman KA. High performance liquid chromatography as a screening tool for classical beta thalassemia trait in Malaysia. Malaysian J Med Sci. 2001;8:40-6.

Tyagi S, Kabra M, Tandon N, Saxena R, Patil HP, Choudhry VP. Clinico-Haematological profile of thalassemia patients. Int J Hum Genet. 2003;3:251-8.

Sachdev R, Dam AR, TyagiG. Detection of Hb variants and hemoglobinopathies in Indian population using HPLC: report of 2600 cases. Indian J Pathol Microbiol. 2010;53:57-62.

Mohanty D, Colah RB, Gorakshakar AC, Patel RZ, Master DC, Mahanta J, et al. Prevalence of β-thalassemia and other haemoglobinopathies in six cities in India: a multicentre study. J Commun Genet. 2013;4:33-42.

Phadke SR, Agarwal S. Phenotype score to grade the severity of thalassemia intermedia. Indian J Pediatr. 2003;70:477-81.

Frischer H. Bowman J. Hemoglobin E, an oxidatively unstable mutation. J Lab Clin Med. 1975;85:531-9.

Itano H. A third abnormal hemoglobin associated with hereditary hemolytic anemia. Proc Nat Acad Sci USA. 1951;37:775-7.

Madan N, Sharma S, Sood SK, Colah R, Bhatia HM. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16:16-25.

Mohanty D, Mukherjee MB, Colah RB, Wadia M, Ghosh K, Chottray GP et al. Iron deficiency anaemia in sickle cell disorders in India. Indian J Med Res. 2008;127:366-9.




How to Cite

Jain, P., Kumar, V., Sen, R., & Bhargava, S. (2016). Prevalence of haemoglobinopathies in anemic females. International Journal of Research in Medical Sciences, 4(10), 4329–4334.



Original Research Articles